glp-1 agonist indications GLP1 medicines now address weight loss and other health conditions through innovative formulations and expanded indications, highlighting key questions about their efficacy and safety. https://ja.ma/3JZg8l3 Dosage of GLP-1 analogues |

Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione

Fatty liver disease can cause liver inflammation and damage that can progress into cirrhosis

2024;326(3):E26876

This observation aligns with previous work showing that pharmacological inhibition or genetic ablation of NMDA receptors in agouti-related-protein (AgRP)-expressing neurons alters synaptic adaptation to fasting 39,40

Acknowledgments The authors wish to thank Mohammad Yassine, BPharm, MSc and Racha Aaraj, Pharm D, MSc, MPH from Phoenix Clinical Research for the support in the preparation of this manuscript

Notably, although gallbladder disorders frequently manifest, advanced gastrointestinal complications such as intestinal obstruction and periprocedural aspiration, and emergent concerns regarding suicidality and ocular problems require further longitudinal studies to refine the usage guidelines for GLP-1 RAs in susceptible populations